Síndrome das pernas inquietas: diagnóstico e tratamento. Opinião de especialistas brasileiros
Nenhuma Miniatura disponível
Data
2007-09-01
Autores
Aloe, Flávio
Alves, Rosana S Cardoso
Andrade, Luiz Augusto Franco [UNIFESP]
Assis,Márcia
Bacelar, Andrea
Bezerra, Márcio
Cardoso, Francisco [UNIFESP]
Ferraz, Henrique Ballalai [UNIFESP]
Fonseca, Ronaldo Guimarães
Horta, Wagner
Orientadores
Tipo
Artigo
Título da Revista
ISSN da Revista
Título de Volume
Resumo
This article contains the conclusions of the November 17-18, 2006 meeting of the Brazilian Study Group of Restless Legs Syndrome (GBE-SPI) about diagnosis and management of restless legs syndrome (RLS). RLS is characterized by abnormal sensations mostly but not exclusively in the legs which worsen in the evening and are improved by motion of the affected body part. its diagnosis is solely based on clinical findings. Therapeutic agents with efficacy supported by Class I studies are dopamine agonists, levodopa and gabapentine. Class 11 studies support the use of slow release valproic acid, clonazepan and oxycoclone. The GBE-SPI recommendations for management of SPI are sleep hygiene, withdrawal of medications capable of worsening the condition, treatment of comorbidities and pharmacological agents. The first choice agents are dopaminergic drugs, second choice are gabapentine or oxycodone, and the third choice are clonazepan or slow release valproic acid.
Descrição
Citação
Arquivos De Neuro-psiquiatria. Sao Paulo Sp: Assoc Arquivos Neuro- Psiquiatria, v. 65, n. 3A, p. 721-727, 2007.